info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Aptamers Companies

Aptamers companies are at the forefront of innovative molecular technologies. Specializing in research, development, and production, these organizations provide aptamer-based solutions for various applications, including diagnostics and therapeutics, showcasing their commitment to advancing precision medicine and molecular biology.

Aptamers Market

 


Latest Aptamers Companies Updates:


Aptamer Group signs material agreement with genetic medicines company: An undisclosed life science research company entered into a significant commercial agreement with Aptamer Group for the development and commercialization of Optimer-based products.


Launch of Optimer®-Fc as a new reagent solution for immunohistochemistry: This expands the use of Optimers in research and development applications.


Zentek Ltd.'s C19HBA aptamer successfully tested against Omicron XBB 1.5 variant: This demonstrates the potential of aptamers for adapting to rapidly evolving threats like COVID-19.


SomaLogic raises USD 81 million in funding: This investment reinforces the confidence in SomaLogic's proteomics platform utilizing aptamers for disease research and drug discovery.


List of Aptamers companies in the market:



  • SomaLogic Operating Co., Inc.

  • Aptamer Group Inc

  • Aptagen LLC

  • Aptamer Sciences Inc.

  • Base Pair Biotechnologies Inc.

  • Aptus Biotech SL

  • TriLink Biotechnologies

  • AstraZeneca

  • AM Biotechnologies

  • Aptadel Therapeutics

  • Ophthotech Corporation


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.